Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07644494
Distensibility Index of Inferior Vena Cava in Assessing Fluid Responsiveness: The Impact of Spontaneous Respiratory EffortJingyuan,XuCompleted
NCT07644494Completed
—
Distensibility Index of Inferior Vena Cava in Assessing Fluid Responsiveness: Th...Jingyuan,Xu
NCT07644962
Research Project on the Interaction Between Immune Function and Infectious Diseases in Older Adults and the Development of Prevention and Control StrategiesHuashan HospitalNot Yet Recruiting
NCT07644962Not Yet Recruiting
—
Research Project on the Interaction Between Immune Function and Infectious Disea...Huashan Hospital
NCT07645664
Scar Management Through Serial CastingCentre hospitalier de l'Université de Montréal (CHUM)Not Yet RecruitingNot Applicable
NCT07645664Not Yet Recruiting
Not Applicable
Scar Management Through Serial CastingCentre hospitalier de l'U...
NCT07644884
Effects of Deltoid Strengthening Exercises in Patients With Adhesive CapsulitisRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07644884Not Yet Recruiting
Not Applicable
Effects of Deltoid Strengthening Exercises in Patients With Adhesive CapsulitisRiphah International Univ...
NCT07645157
Sertraline Combined With Multi-Strain Probiotics for Adolescent DepressionFirst Affiliated Hospital of Chongqing Medical UniversityRecruitingPhase 2
NCT07645157Recruiting
Phase 2
Sertraline Combined With Multi-Strain Probiotics for Adolescent DepressionFirst Affiliated Hospital...
NCT07645859
Comparison of High-Intensity Interval Training With Moderate-Intensity Continuous Training in Chronic Non-Specific Low Back Pain PatientsDow University of Health SciencesRecruitingNot Applicable
NCT07645859Recruiting
Not Applicable
Comparison of High-Intensity Interval Training With Moderate-Intensity Continuou...Dow University of Health...
NCT07644481
Efficacy and Safety of the CloB2M (Clofarabine Combined With Busulfan and Melphalan) Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients With Acute Myeloid Leukemia in First Complete RemissionInstitute of Hematology & Blood Diseases Hospital, ChinaNot Yet RecruitingNot Applicable
NCT07644481Not Yet Recruiting
Not Applicable
Efficacy and Safety of the CloB2M (Clofarabine Combined With Busulfan and Melpha...Institute of Hematology &...
NCT07646535
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Primary AldosteronismShenzhen Salubris Pharmaceuticals Co., Ltd.Not Yet RecruitingPhase 2
NCT07646535Not Yet Recruiting
Phase 2
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses i...Shenzhen Salubris Pharmac...
NCT07643909
Health-Related Social Needs Food Boxes Delivery ProgramBoston Medical CenterNot Yet RecruitingNot Applicable
NCT07643909Not Yet Recruiting
Not Applicable
Health-Related Social Needs Food Boxes Delivery ProgramBoston Medical Center
NCT07645235
A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating WomenBiomedical Advanced Research and Development AuthorityNot Yet RecruitingPhase 1
NCT07645235Not Yet Recruiting
Phase 1
A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating Wom...Biomedical Advanced Resea...
NCT07644143
Effect of A Theory-based Multicomponent eHealth Intervention ProgramTaipei Medical UniversityNot Yet RecruitingNot Applicable
NCT07644143Not Yet Recruiting
Not Applicable
Effect of A Theory-based Multicomponent eHealth Intervention ProgramTaipei Medical University
NCT07646028
R-3750 in Patients With Late-Stage Acute Respiratory Distress Syndrome (ARDS)Rise Therapeutics LLCNot Yet RecruitingPhase 1
NCT07646028Not Yet Recruiting
Phase 1
R-3750 in Patients With Late-Stage Acute Respiratory Distress Syndrome (ARDS)Rise Therapeutics LLC
NCT07645144
FES-assisted Gait Training for Incomplete Spinal Cord InjuryStichting ReadeEnrolling By InvitationNot Applicable
NCT07645144Enrolling By Invitation
Not Applicable
FES-assisted Gait Training for Incomplete Spinal Cord InjuryStichting Reade
NCT07644416
Using Virtual Reality Travel to Reduce Loneliness in Older AdultsIndiana UniversityNot Yet RecruitingNot Applicable
NCT07644416Not Yet Recruiting
Not Applicable
Using Virtual Reality Travel to Reduce Loneliness in Older AdultsIndiana University
NCT07643805
Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Patients With Relapsed/ Refractory DLBCLThe First Affiliated Hospital with Nanjing Medical UniversityNot Yet RecruitingPhase 1
NCT07643805Not Yet Recruiting
Phase 1
Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Pat...The First Affiliated Hosp...
NCT07644897
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen UniversityRecruitingPhase 2
NCT07644897Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients...Sun Yat-sen University
NCT07644039
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced MalignanciesPharmaMarRecruitingPhase 1
NCT07644039Recruiting
Phase 1
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advan...PharmaMar
NCT07644923
Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated CoagulationNYU Langone HealthNot Yet RecruitingPhase 4
NCT07644923Not Yet Recruiting
Phase 4
Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled Wit...NYU Langone Health
NCT07645768
Is Anterior Reversed Proximal Humeral Locking Plate System (PHILOS) a Safe Alternative to Conventional Posterior Double Plating in Extra-Articular Distal Shaft Humeral FracturesCairo UniversityActive Not RecruitingNot Applicable
NCT07645768Active Not Recruiting
Not Applicable
Is Anterior Reversed Proximal Humeral Locking Plate System (PHILOS) a Safe Alter...Cairo University
Result Breakdown
Not yet recruiting13 (65%)
Recruiting4 (20%)
Completed1 (5%)
Enrolling by invitation1 (5%)
Active, not recruiting1 (5%)
not_applicable9 (45%)
Phase 14 (20%)
Phase 23 (15%)
Not Specified2 (10%)
Phase 42 (10%)